Skip to main content

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

Recent Quotes

View More
Symbol Price Change (%)
AMZN  228.32
-1.98 (-0.86%)
AAPL  270.43
+0.73 (0.27%)
AMD  256.88
-7.45 (-2.82%)
BAC  53.38
+0.80 (1.52%)
GOOG  289.31
+14.14 (5.14%)
META  658.68
-92.99 (-12.37%)
MSFT  526.77
-14.78 (-2.73%)
NVDA  203.23
-3.81 (-1.84%)
ORCL  262.63
-12.67 (-4.60%)
TSLA  444.69
-16.82 (-3.64%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.